[go: up one dir, main page]

FI894546A - Förfarande för framställning av nya 2'-halogenmetyliden, 2'-etenyliden- och 2'-etynyladenosinderivat - Google Patents

Förfarande för framställning av nya 2'-halogenmetyliden, 2'-etenyliden- och 2'-etynyladenosinderivat Download PDF

Info

Publication number
FI894546A
FI894546A FI894546A FI894546A FI894546A FI 894546 A FI894546 A FI 894546A FI 894546 A FI894546 A FI 894546A FI 894546 A FI894546 A FI 894546A FI 894546 A FI894546 A FI 894546A
Authority
FI
Finland
Prior art keywords
halomethylidene
ethynyladenosine
ethenylidene
derivatives
preparation
Prior art date
Application number
FI894546A
Other languages
English (en)
Finnish (fi)
Other versions
FI894546A0 (sv
FI94763C (sv
FI94763B (sv
Inventor
James R Mccarthy
Michael L Edwards
David M Stemerick
Esa T Jarvi
Nellikunja J Prakash
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI894546A0 publication Critical patent/FI894546A0/sv
Publication of FI894546A publication Critical patent/FI894546A/sv
Application granted granted Critical
Publication of FI94763B publication Critical patent/FI94763B/sv
Publication of FI94763C publication Critical patent/FI94763C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052Imidazole radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056Triazole or tetrazole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI894546A 1988-09-27 1989-09-26 Förfarande för framställning av nya 2'-halogenmetyliden, 2'-etenyliden- och 2'-etynyladenosinderivat FI94763C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24991188A 1988-09-27 1988-09-27
US24991188 1988-09-27
US38939189A 1989-08-03 1989-08-03
US38939189 1989-08-03

Publications (4)

Publication Number Publication Date
FI894546A0 FI894546A0 (sv) 1989-09-26
FI894546A true FI894546A (sv) 1990-03-28
FI94763B FI94763B (sv) 1995-07-14
FI94763C FI94763C (sv) 1995-10-25

Family

ID=26940460

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894546A FI94763C (sv) 1988-09-27 1989-09-26 Förfarande för framställning av nya 2'-halogenmetyliden, 2'-etenyliden- och 2'-etynyladenosinderivat

Country Status (18)

Country Link
EP (1) EP0365849B1 (sv)
JP (1) JP2968002B2 (sv)
KR (1) KR0146333B1 (sv)
CN (1) CN1046334A (sv)
AR (1) AR248283A1 (sv)
AT (1) ATE111477T1 (sv)
AU (1) AU621664B2 (sv)
CA (1) CA1336903C (sv)
DE (1) DE68918215T2 (sv)
DK (1) DK171237B1 (sv)
ES (1) ES2063796T3 (sv)
FI (1) FI94763C (sv)
HU (1) HU204843B (sv)
IE (1) IE63561B1 (sv)
IL (1) IL91773A (sv)
NO (1) NO171857C (sv)
NZ (1) NZ230766A (sv)
PT (1) PT91803B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206244A (en) * 1990-10-18 1993-04-27 E. R. Squibb & Sons, Inc. Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines
US5340816A (en) * 1990-10-18 1994-08-23 E. R. Squibb & Sons, Inc. Hydroxymethyl(methylenecyclopentyl) purines and pyrimidines
FR2668153B1 (fr) * 1990-10-22 1995-03-31 Pasteur Merieux Serums Vacc Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments les contenant.
ATE146183T1 (de) * 1992-05-12 1996-12-15 Merrell Pharma Inc Verfahren zur herstellung von ribonukleotid- reduktasehemmern
US5589587A (en) * 1992-05-12 1996-12-31 Merrell Pharmaceuticals Inc. Process for the preparation of ribonucleotide reductase inhibitors
US5627053A (en) * 1994-03-29 1997-05-06 Ribozyme Pharmaceuticals, Inc. 2'deoxy-2'-alkylnucleotide containing nucleic acid
US5811408A (en) * 1994-07-12 1998-09-22 Yamasa Corporation 2'-deoxy-2'-(substituted or unsubstituted)methylidene-4'-thionucleosides
DE60024257T2 (de) 1999-06-09 2006-07-20 Anticancer Inc., San Diego Modulatoren der methylierung zur kontrolle von bakterieller virulenz
US6579857B1 (en) 1999-06-11 2003-06-17 Evanston Northwestern Healthcare Research Institute Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
WO2003068162A2 (en) * 2002-02-14 2003-08-21 Pharmasset Ltd. Modified fluorinated nucleoside analogues
LT2794627T (lt) 2011-12-22 2019-01-10 Alios Biopharma, Inc. Pakeistieji nukleozidai, nukleotidai ir jų analogai
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL84414A0 (en) * 1986-11-14 1988-04-29 Ciba Geigy Ag N9-cyclopentyl-substituted adenine derivatives
EP0310673B1 (en) * 1987-03-19 1995-07-05 Yamasa Shoyu Kabushiki Kaisha 2'-alkylidenepyrimidine nucleoside derivatives, process for their preparation, and their use
NZ225906A (en) * 1987-08-26 1990-10-26 Merrell Dow Pharma Aristeromycin/adenosine derivatives and pharmaceutical compositions
ZA894534B (en) * 1988-06-20 1990-03-28 Merrell Dow Pharma Novel neplanocin derivatives

Also Published As

Publication number Publication date
CA1336903C (en) 1995-09-05
JP2968002B2 (ja) 1999-10-25
ATE111477T1 (de) 1994-09-15
AU4176089A (en) 1990-04-05
IE63561B1 (en) 1995-05-17
FI894546A0 (sv) 1989-09-26
IE893080L (en) 1990-03-27
FI94763C (sv) 1995-10-25
DE68918215D1 (de) 1994-10-20
EP0365849A2 (en) 1990-05-02
HUT50844A (en) 1990-03-28
KR900004736A (ko) 1990-04-12
AU621664B2 (en) 1992-03-19
IL91773A (en) 1994-02-27
ES2063796T3 (es) 1995-01-16
AR248283A1 (es) 1995-07-12
DK473289A (da) 1990-03-28
PT91803B (pt) 1995-05-31
IL91773A0 (en) 1990-06-10
NZ230766A (en) 1992-07-28
KR0146333B1 (ko) 1998-08-01
NO171857B (no) 1993-02-01
EP0365849A3 (en) 1990-12-27
NO893826L (no) 1990-03-28
DE68918215T2 (de) 1995-02-02
CN1046334A (zh) 1990-10-24
EP0365849B1 (en) 1994-09-14
DK473289D0 (da) 1989-09-26
JPH02160769A (ja) 1990-06-20
DK171237B1 (da) 1996-08-05
FI94763B (sv) 1995-07-14
HU204843B (en) 1992-02-28
NO171857C (no) 1993-05-12
PT91803A (pt) 1990-03-30
NO893826D0 (no) 1989-09-26

Similar Documents

Publication Publication Date Title
FI890282A0 (sv) Förfarande för framställning av terapeutiskt användbara 23,24-didehydro-25-hydroxikalciferolderivat
NO171367C (no) Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider
NO894539D0 (no) Fremgangsmaate for fremstilling av nye 2'-halomethyliden-,2'-ethenyliden- og 2'-ethynylcytidin-, uriden og guanosinderivater.
FI894546A (sv) Förfarande för framställning av nya 2'-halogenmetyliden, 2'-etenyliden- och 2'-etynyladenosinderivat
MX9203459A (es) Nuevos derivados de 2'-halometilideno, 2'-etenilideno y 2'-etinilcitidina, uridina y guanosina.
FI91961C (sv) Förfarande för tillverkning av (S)- -etyl-2-oxo-1-pyrrolidinacetamid
FI895662A0 (sv) Förfarande för framställning av en 3,4-difluorsubstituerad bensen
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
NO891985L (no) Fremgangsmaate for fremstilling av dibenzotiofen- og tioxanten-derivater.
FI891111A (sv) Förfarande för framställning av 1,4-dihydropyridinderivat
HU9202873D0 (en) 1,4-dihydropyridine derivatives of paf-antagonistic effect
HU8902302D0 (en) Process for preparation of 1,2-hydroxy-phosphonates and derivatives thereof
FI904673A0 (sv) Framställning av 2,6-dioxopiperidinderivat
FI93010B (sv) Förfarande för framställning av 1,5-bensotiazepinderivat
EP0344112A3 (en) Substituted bisacyloxynaphthacenes, and process for the preparation of tetrathiotetracenes
PL276723A1 (en) Method for preparation of the new, n-phenylcarbamyle derivatives of difurylethane and difurylvinylchloride
EP0267537A3 (en) Process for the preparation of vinylglyoxal derivatives, vinylglyoxal derivatives and their use
FR2603282B1 (fr) Derives d'isoquinoleine
FI92393B (sv) Förfarande för framställning av 1,5-bensotiazepinderivat
MC1816A1 (fr) Derives d'isoquinoleine
NO922253D0 (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater
NO172488C (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater
NO171314C (no) Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider
NO172345C (no) Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider
NO171315C (no) Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: MERRELL DOW PHARMACEUTICALS INC.

MA Patent expired